Altimmune Inc (NASDAQ: ALT) on Friday, plunged -3.22% from the previous trading day, before settling in for the closing price of $7.15. Within the past 52 weeks, ALT’s price has moved between $3.55 and $11.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -67.83% annually for the last half of the decade. The company achieved an average annual earnings per share of 5.73%. With a float of $80.26 million, this company’s outstanding shares have now reached $81.11 million.
In an organization with 59 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -205.0%, operating margin of -490965.0%, and the pretax margin is -454605.0%.
Altimmune Inc (ALT) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Altimmune Inc is 1.04%, while institutional ownership is 47.38%. The most recent insider transaction that took place on Mar 17 ’25, was worth 5,784. In this transaction Director of this company bought 1,000 shares at a rate of $5.78, taking the stock ownership to the 1,000 shares. Before that another transaction happened on Mar 13 ’25, when Company’s Chief Financial Officer bought 10,000 for $5.20, making the entire transaction worth $51,996. This insider now owns 10,000 shares in total.
Altimmune Inc (ALT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 5.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.60% during the next five years compared to 3.48% growth over the previous five years of trading.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
Altimmune Inc (ALT) is currently performing well based on its current performance indicators. A quick ratio of 15.82 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 28063.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.25, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.57 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
Let’s dig in a bit further. During the last 5-days, its volume was 5.11 million. That was better than the volume of 2.57 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 77.43%. Additionally, its Average True Range was 0.47.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 85.74%, which indicates a significant increase from 75.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.22% in the past 14 days, which was lower than the 74.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.31, while its 200-day Moving Average is $6.55. However, in the short run, Altimmune Inc’s stock first resistance to watch stands at $7.30. Second resistance stands at $7.68. The third major resistance level sits at $7.96. If the price goes on to break the first support level at $6.64, it is likely to go to the next support level at $6.37. The third support level lies at $5.99 if the price breaches the second support level.
Altimmune Inc (NASDAQ: ALT) Key Stats
Market capitalization of the company is 561.26 million based on 81,107K outstanding shares. Right now, sales total 20 K and income totals -95,060 K. The company made 10 K in profit during its latest quarter, and -19,580 K in sales during its previous quarter.
